| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy
|
Brusamolino, E.
|
|
|
5 |
S2 |
p. S53-S57
|
artikel
|
| 2 |
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study*
|
Fisher, R.I.
|
|
|
5 |
S2 |
p. S91-S95
|
artikel
|
| 3 |
Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: The European Bone Marrow Transplant Group experience
|
Schouten, H.C.
|
|
|
5 |
S2 |
p. S147-S149
|
artikel
|
| 4 |
Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: A randomized trial from the Lymphoma Group of Central Sweden
|
Kimby, E.
|
|
|
5 |
S2 |
p. S67-S71
|
artikel
|
| 5 |
Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose Adriamycin-based regimens*
|
Grogan, L.
|
|
|
5 |
S2 |
p. S47-S51
|
artikel
|
| 6 |
Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: A case-controlled analysis of the EBMT Registry data
|
Liberti, G.
|
|
|
5 |
S2 |
p. S151-S153
|
artikel
|
| 7 |
Copyright
|
|
|
|
5 |
S2 |
p. iv
|
artikel
|
| 8 |
Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy*
|
Zagonel, V.
|
|
|
5 |
S2 |
p. S127-S132
|
artikel
|
| 9 |
Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphoma
|
Canellos, G.P.
|
|
|
5 |
S2 |
p. S121-S122
|
artikel
|
| 10 |
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: Results of a randomized double-blind placebo-controlled study with intensified COP-BLAM ± rhGM-CSF
|
Engelhard, M.
|
|
|
5 |
S2 |
p. S123-S125
|
artikel
|
| 11 |
Early bone marrow transplantation in Hodgkin's disease
|
Armitage, J.O.
|
|
|
5 |
S2 |
p. S161-S163
|
artikel
|
| 12 |
Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy
|
Brusamolino, E.
|
|
|
5 |
S2 |
p. S101-S106
|
artikel
|
| 13 |
Editorial board
|
|
|
|
5 |
S2 |
p. ii
|
artikel
|
| 14 |
EORTC study of non-Hodgkin's lymphoma: Phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma
|
Somers, R.
|
|
|
5 |
S2 |
p. S85-S89
|
artikel
|
| 15 |
Haemopoietic growth factors and dose intensity in high-grade and intermediate-grade lymphoma
|
Pettengell, R.
|
|
|
5 |
S2 |
p. S133-S141
|
artikel
|
| 16 |
High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: The EBMT experience
|
Sweetenham, J.W.
|
|
|
5 |
S2 |
p. S155-S159
|
artikel
|
| 17 |
Hodgkin's disease in children: Combined modality treatment for stages IA, IB, and IIA
|
Schellong, G.
|
|
|
5 |
S2 |
p. S113-S115
|
artikel
|
| 18 |
Hodgkin's disease in patients with HIV infection and in the general population: Comparison of clinicopathological features and survival*
|
Errante, D.
|
|
|
5 |
S2 |
p. S37-S40
|
artikel
|
| 19 |
Hodgkin's disease with a mediastinal mass greater than 10 cm: Results of four different treatment approaches
|
Preti, A.
|
|
|
5 |
S2 |
p. S97-S100
|
artikel
|
| 20 |
Hybrid LOPP/EVA is not better than LOPP alternating with EVAP: A prematurely terminated British National Lymphoma Investigation randomized trial
|
Hancock, B.W.
|
|
|
5 |
S2 |
p. S117-S120
|
artikel
|
| 21 |
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: High remission rates and reversion to negative of peripheral blood bcl-2 rearrangement*
|
McLaughlin, P.
|
|
|
5 |
S2 |
p. S73-S77
|
artikel
|
| 22 |
Late mortality in young BNLI patients cured of Hodgkin's disease
|
Hudson, B. Vaughan
|
|
|
5 |
S2 |
p. S65-S66
|
artikel
|
| 23 |
List of contributors
|
|
|
|
5 |
S2 |
p. vii
|
artikel
|
| 24 |
Low-grade lymphoma 1993: State of the art
|
Horning, S.J.
|
|
|
5 |
S2 |
p. S23-S27
|
artikel
|
| 25 |
Lymphoma complicating immunodeficiency disorders
|
Levine, A.M.
|
|
|
5 |
S2 |
p. S29-S35
|
artikel
|
| 26 |
Management of lymphoma in the 1990s: Introduction to the Proceedings of the Fifth International Conference on Malignant Lymphoma
|
Stupp, R.
|
|
|
5 |
S2 |
p. S1-S3
|
artikel
|
| 27 |
Modern treatment of malignant lymphomas: A multidisciplinary approach?
|
Bonadonna, G.
|
|
|
5 |
S2 |
p. S5-S16
|
artikel
|
| 28 |
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma
|
Rohatiner, A.Z.S.
|
|
|
5 |
S2 |
p. S143-S146
|
artikel
|
| 29 |
Original article: Fludarabine – present status and future developments in chronic lymphocytic leukemia and lymphoma
|
Keating, M.J.
|
|
|
5 |
S2 |
p. S79-S83
|
artikel
|
| 30 |
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease
|
Noordijk, E.M.
|
|
|
5 |
S2 |
p. S107-S112
|
artikel
|
| 31 |
Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas
|
Hagemeister, F.B.
|
|
|
5 |
S2 |
p. S41-S46
|
artikel
|
| 32 |
Subject index Volume 5, supplement 2
|
|
|
|
5 |
S2 |
p. S165-S166
|
artikel
|
| 33 |
Table of Contents
|
|
|
|
5 |
S2 |
p. v-vi
|
artikel
|
| 34 |
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy*
|
Hagemeister, F.B.
|
|
|
5 |
S2 |
p. S59-S63
|
artikel
|
| 35 |
The treatment of Hodgkin's disease*
|
Rosenberg, S.A.
|
|
|
5 |
S2 |
p. S17-S21
|
artikel
|
| 36 |
Title Page
|
|
|
|
5 |
S2 |
p. iii
|
artikel
|
Tijdschrift beschrijving